TFP
IDXX icon

Triune Financial Partners’s Idexx Laboratories IDXX Stock Holding History

Triune Financial Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-628
Closed -$256K – 30
2022
Q4 		$256K Hold
628
– – 0.12% 21
2022
Q3 		$205K Hold
628
– – 0.12% 21
2022
Q2 		$220K Hold
628
– – 0.12% 21
2022
Q1 		$344K Hold
628
– – 0.18% 14
2021
Q4 		$414K Buy
+628
New +$394K 0.21% 12
2021
Q2 		$397K Buy
+628
New +$347K 0.32% 11

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Triune Financial Partners's IDXX Position: Q1 2023 in Review

Triune Financial Partners sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 628 shares — an estimated $256K sold.

Triune Financial Partners first reported a position in IDXX in Q2 2021 and held it in 6 quarters. The position peaked at $414K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Triune Financial Partners reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Triune Financial Partners sold 628 Idexx Laboratories shares in Q1 2023, an estimated $256K.
  • Triune Financial Partners first reported a position in Idexx Laboratories in Q2 2021 and held it in 6 quarters.
  • Triune Financial Partners's Idexx Laboratories position peaked at $414K in Q4 2021.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Triune Financial Partners's 13F filing for Q1 2023, filed 6 Dec 2024.